Novo Nordisk Launches Safe Pharmaceuticals Disposal Initiative for Employees

Novo Nordisk Global Business Services launches safe pharmaceuticals disposal initiative for employees

Overview

Novo Nordisk Global Business Services (GBS) announced the launch of a sustainable initiative called Eco Med Safe aimed at promoting safe and responsible disposal of pharmaceutical products, on World Patient Safety Day, observed on September 17 in partnership with Connect and Heal Foundation.

About the Programme

• Launched internally for employees, the programme is designed to minimise environmental impact and enhance public health by safely disposing unused or expired medicines. 
• The comprehensive eco-pharmacovigilance initiative is a pivotal step towards Novo Nordisk’s commitment to minimise environmental impact and maximise our positive impact on public health.

Novo Nordisk Statement on The Programme

Through this programme, we aim to address the significant environmental risks posed by improper disposal of medications. The safe removal of expired or unused pharmaceuticals prevents contamination of water systems and soil, protecting both ecosystems, human and animal health. This initiative is also likely to contribute to mitigating the development of antibiotic-resistant bacteria which is a growing global concern linked to the presence of antibiotics in the environment,” stated Dr. Prasanna Kumar T S, vice president, global safety, Novo Nordisk Global Business Services.

From MD: Novo Nordisk Global Business Services

• Building on our Circular for Zero environmental strategy, we view the Sustainable Development Goals representing good health & sustainable communities as a great opportunity to enhance our sustainability efforts. The Eco Med Safe program presents an innovative educational platform, promoting responsible medication disposal practices and significantly reducing environmental risks.”
• Education is essential for achieving success in this endeavour, and we are enthusiastic about partnering with other companies and the broader healthcare community. Together, we can better understand the impacts of improper disposal of unused medicines and support voluntary community collection programs,"" said John Dawber, corporate vice president & managing director, Novo Nordisk Global Business Services.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!